Singular Genomics Systems...

NASDAQ: OMIC · Real-Time Price · USD
20.01
0.00 (0.00%)
At close: Feb 20, 2025, 3:55 PM

Singular Genomics Systems Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-94.82M -90.88M -98.77M
Depreciation & Amortization
7.22M 6.03M 1.13M
Stock-Based Compensation
11.4M 13.67M 9.23M
Other Working Capital
677K -1.25M -4.76M
Other Non-Cash Items
4.79M 901K 35.48M
Deferred Income Tax
n/a n/a 4.14M
Change in Working Capital
-2.25M -16.82M -2.91M
Operating Cash Flow
-73.65M -87.09M -51.7M
Capital Expenditures
-970K -6.02M -4.86M
Cash Acquisitions
n/a 33.54M 126M
Purchase of Investments
-183.59M -174.71M -195.68M
Sales Maturities Of Investments
198.37M 141.17M 69.69M
Other Investing Acitivies
n/a -33.54M -126M
Investing Cash Flow
13.81M -39.57M -130.86M
Debt Repayment
n/a n/a 130.6M
Common Stock Repurchased
-19K -450K -38K
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
715K 1.35M 4.37M
Financial Cash Flow
696K 901K 372.13M
Net Cash Flow
-59.14M -125.76M 189.57M
Free Cash Flow
-74.62M -93.12M -56.56M